Generic Drugs Market Report PPT: Global Industry Trends, Share, Size and Forecast 2020 - 20225

Global Generic Drugs Market Research Report and Forecast 2025

Report Edition: 2020 © 2020 IMARC All Rights Reserved

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Global Generic Drugs Market Overview: According to the latest report by IMARC Group, titled “ Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025 ,� the global generic drug market size reached US$ 367 Billion in 2019, registering a CAGR of 5.7% during 2014-2019. Generic drugs are bioequivalent of brand-name drugs in terms of safety, strength, quality, dosage form, stability, impact, intended use and the route of administration. These drugs are proven to be as safe and effective as their already marketed brand-name formulation. Although certain characteristics, such as color, shape and flavoring, that do not affect the safety and effectiveness of the medicines can differ from the original version, generic variants are prepared from the same active ingredients as their branded counterparts while working in the same manner and amount of time.

Generic drug manufacturers do not have to invest in marketing, drug research or drug development, which makes these medicines cost-effective, thus contributing to their widespread preference.

Request for a free sample report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Report Description and Highlights

157.3 146.7 152.0 141.4 136.1 125.5 130.8

160 140 120 100 80 60 40 20 0

120.2 2012

2013

2014

2015

2016

2017

2018

2019

In Billion US$

In Billion US$

Report Description

180 160 140 120 100 80 60 40 20 0

160.0 2020

175.9

181.2

186.5

165.3

170.6

2021

2022

2023

2024

2025

Global Generic Drugs Market Trends The global market is primarily driven by a significant increase in cardiometabolic risk factors among the masses. In line with this, there is an increasing prevalence of hypertension, diabetes, dyslipidemia, metabolic syndrome and obesity, owing to the confluence of various factors, including sedentary lifestyles, changing dietary patterns and hectic working schedules. This has contributed to a significant increase in the uptake of medicines, thereby facilitating the growth of the market.

Report Description and Highlights

Report Description

In addition to this, the high costs associated with the medication of several chronic and lifestyle diseases have increased the consumer inclination toward affordable variants, which is boosting the demand for generic drugs. Moreover, the patent expiration of key blockbuster drugs, coupled with numerous favorable initiatives undertaken by the governments of various countries to promote the use of generic drugs, is expected to provide a thrust to the market growth. Several regulatory bodies are conducting rigorous reviews to ensure optimal standards during the manufacturing of these drugs. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 497 Billion by 2025, growing at a CAGR of 5.2% during 2020-2025.

Global Generic Drugs Market Segmentation: Market Segmentation by Therapy Area • • • • • •

CNS Cardiovascular Dermatology Genitourinary/Hormonal Respiratory Rheumatology

Report Description and Highlights

Report Description • • •

Diabetes Oncology Others

Based on the therapy area, cardiovascular diseases represent the largest segment. Other major segments include central nervous system, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, oncology and others.

For more information, click here: https://www.imarcgroup.com/generic-drug-manufacturing-plant Market Segmentation by Drug Delivery • • • •

Oral Injectables Dermal/Topical Inhalers

On the basis of the drug delivery, the market has been classified into oral, injectables, dermal/topical and inhalers. At present, oral generic drugs account for the majority of the total market share.

Report Description and Highlights

Report Description

Market Segmentation by Distribution Channel • •

Retail Pharmacies Hospital Pharmacies

Based on the distribution channel, the market has been bifurcated into retail and hospital pharmacies, wherein retail pharmacies exhibit a clear dominance in the market.

Market Segmentation by Region • • • • • • • •

United States China Brazil Germany France India United Kingdom Japan

Report Description and Highlights

Report Description • • •

Canada Italy Others

On the geographical front, the United States holds the leading position in the market. Some of the other major regions include China, Brazil, Germany, France, India, the United Kingdom, Japan, Canada and Italy.

Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players.

• • • • • • •

Teva Pharmaceuticals Industries Ltd Mylan N.V Novartis International AG Pfizer Inc Sun Pharmaceutical Industries Limited Fresenius SE & Co KGaA

Report Description and Highlights

Report Description • • • •

Lupin Limited Endo Pharmaceuticals Inc. Aurobindo Pharma Limited Aspen Pharmacare Holdings Limited

Browse Related Report •

Pain Management Drugs Market Report: https://www.imarcgroup.com/pain-management-drugs-market

•

Depression Drugs Market Report: https://www.imarcgroup.com/depression-drugs-market

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

Š 2020 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com